Trials / Conditions / B-cell Lymphoid Malignancies
B-cell Lymphoid Malignancies
4 registered clinical trials studyying B-cell Lymphoid Malignancies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies NCT05263739 | Shanghai Escugen Biotechnology Co., Ltd | Phase 1 |
| Completed | A Phase 1 Study of ESG206 in Adult Subjects With B-cell Lymphoid Malignancies NCT05822843 | Shanghai Escugen Biotechnology Co., Ltd | Phase 1 |
| Withdrawn | Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malign NCT04684979 | Baptist Health South Florida | Phase 2 |
| Completed | BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies NCT02569476 | BeiGene | Phase 1 |